aniracetam
Selected indexed studies
- Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries. (CNS Drug Rev, 2002) [PMID:12070527]
- Aniracetam Ameliorates Attention Deficit Hyperactivity Disorder Behavior in Adolescent Mice. (eNeuro, 2025) [PMID:40118526]
- Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. (Drugs Aging, 1994) [PMID:8199398]
_Worker-drafted node — pending editorial review._
Connections
aniracetam helps
aniracetam protects against
Sources
- Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries. (2002) pubmed
- Aniracetam Ameliorates Attention Deficit Hyperactivity Disorder Behavior in Adolescent Mice. (2025) pubmed
- Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. (1994) pubmed
- Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease. (2024) pubmed
- Aniracetam does not improve working memory in neurologically healthy pigeons. (2019) pubmed
- Aniracetam does not alter cognitive and affective behavior in adult C57BL/6J mice. (2014) pubmed
- Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease. (1998) pubmed
- [3H]aniracetam binds to specific recognition sites in brain membranes. (1995) pubmed
- Piracetam and aniracetam antagonism of centrally active drug-induced antinociception. (1996) pubmed
- Aniracetam attenuates apoptosis of astrocytes subjected to simulated ischemia in vitro. (2002) pubmed